ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

MSKCC oncologist settles insider trading case with SEC.

November 11, 2005

Mihich to Be Sixth New NCAB appointee; Centers Worried About Core Grants, Role In 200 AD Goals

May 25, 1984

Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation

September 5, 2014

NCI to Get 43 Out Of 200 New Aids Positions, 15 Others; Roper Says That’s “Fair”

November 11, 1988

Mentholated Cigarettes Cause No More Lung Cancer, Deaths

March 25, 2011